Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients

NCT00828503 is registered in ClinicalTrials.gov with Marcus Saemann as lead sponsor.

NCT NCT00828503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00828503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
Lead sponsor
Marcus Saemann
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2008
Completion date
June 30, 2014
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus disease